UnknownNot Applicable

Postoperative Analgesic Efficacy of Continuous Wound Infusion After Laparoscopy

South Korea66 participantsStarted 2019-01-21

Plain-language summary

Studies evaluating the effectiveness of continuous wound infusion (CWI) to manage postoperative pain following laparoscopy are markedly lacking. Especially, there was no study comparing CWI and placebo in treating gynecologic laparoscopy. Therefore, the investigators conducted this randomized, double-blind, placebo-controlled trial to investigate whether CWI of local anesthetics was an effective strategy for enhanced recovery after surgery (ERAS), compared with placebo in patients undergoing benign gynecologic laparoscopy.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age between 18 and 80 years, * American Society of Anesthesiologists physical status (ASAPS) classification I-II * the absence of pregnancy at the time of surgery Exclusion Criteria: * allergy to amide local anesthetics including ropivacaine * laparoscopic surgery needing ≥ 3 separate skin incisions * history of ventral or incisional hernia * pre-existing coagulopathy, neurologic or cognitive dysfunction * systemic or regional (especially, umbilicus) infection * previously taking opioids for acute or chronic pain * inability to accurately express their pain.

What they're measuring

postoperative pain

Timeframe: 24-hour after surgery

Trial details

NCT IDNCT03645304

SponsorKangbuk Samsung Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04-03

Contact for this trial

Taejong Song, MD PhD

+821040358405 taejong.song@gmail.com

View on ClinicalTrials.gov More Benign Gynecologic Neoplasm trials